Search
for

    Research 10 of 272

    1. Medications Mostly Associated With Ejaculatory Disorders: Assessment of the Eudra-Vigilance and Food and Drug Administration Pharmacovigilance Databases Entries Urology · 2024
    2. Ejaculations and Benign Prostatic Hyperplasia: An Impossible Compromise? A Comprehensive Review Journal of Clinical Medicine · 2021 · 34 citations
    3. Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis PLOS ONE · 2018 · 19 citations
    4. Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs Pharmacopsychiatry · 2015 · 15 citations
    5. Outcome of Dutasteride 0.5mg in Androgenic Alopecia Scholars journal of applied medical sciences · 2022
    6. 180 The Efficacy of Amoxapine for Ejaculatory Dysfunction The Journal of Sexual Medicine · 2022
    7. Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review Sexual medicine reviews · 2013 · 35 citations
    8. (192) Evaluating Effect of hCG and hCG+rFSH Therapy on Ejaculation Disorders in Middle-Aged Men: A Case Study ˜The œjournal of sexual medicine · 2024
    9. Electron beam tomography quantitation of coronary calcium and assessment for ischemic coronary disease: a complement to stress testing Acc Current Journal Review · 2001 · 1 citations
    10. Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors Uro · 2021 · 6 citations
    All research results →

    Community 1 of 2

    1. PSA: Most men who stay on Fin will see the sexual side effects go away. Stop the fear mongering Reddit · 30 Apr 2022
    All community results →

    Learn

    — no results

    Try a deeper search in learn →